![]() |
|||||||
|
SELECT PUBLICATIONS Bolla M et al. European Organization for Research and Treatment of Cancer. Postoperative radiotherapy after radical prostatectomy: A randomized controlled trial (EORTC trial 22911). Lancet 2005;366:572-8. Abstract D’Amico AV et al. 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: A randomized controlled trial. JAMA 2004;292(7):821-7. Abstract Freedland SJ et al. Obesity, serum prostate specific antigen and prostate size: Implications for prostate cancer detection. J Urol 2006;175(2):500-4. Abstract Pilepich MV et al. Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. Int J Radiat Oncol Biol Phys 2001;50(5):1243-52. Abstract Zelefsky MJ. Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: Results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial. Urol Oncol 2006a;24(4):376-7. Abstract Zelefsky MJ. Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911). Urol Oncol 2006b;24(4):374-5. Abstract Zelefsky MJ et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 2000;55(3):241-9. Abstract |
Editor INTERVIEWS Stephen J Freedland, MD Michael J Zelefsky, MD Mario A Eisenberger, MD Paul F Schellhammer, MD
|